Demonstrates structural and functional disparities surrounding the SH-1 and SH-2 thiols between atrial and ventricular myosin isozymes.
Authors
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for atrial-ventricular myosin differences; should not yet inform clinical myosin-targeted therapies.
Srivastava et al. (1982) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: